Post-Grant Review: The Good, the Bad and the Ugly for Biotechnology Companies

Smitha Uthaman
Vedder Price P.C.
Deborah Lu
Vedder Price P.C.
Thomas Kowalski
Vedder Price P.C.

DOI:https://doi.org/10.5912/jcb499

Abstract:

This paper summarizes the Post-Grant Review process, one of the many interesting aspects of patent reform brought about by the enactment of the America Invents Act, and the effect it may have on how Biotechnology companies conduct business and manage their intellectual property.

Keywords:America Invents Act ,Post-grant review ,law ,patent ,en ,